$ABCL is an AI biotech pure play reporting earnings this Monday.
During covid-19 Abcellera developed LY-CoV555 in under three months from screening to human clinical trials. Within one week of receiving a blood sample from a recovered covid patient, they screened over 5 million immune cells and identified over 500 unique antibody sequences.
Can they repeat the success this time?
https://i.redd.it/mf1aphs1la0h1.png
Posted by Rambok01